Straximm Therapeutics Private Limited
About Straximm Therapeutics Private Limited
Data last updated:
Straximm Therapeutics Private Limited was a private limited company based in Bangalore, Karnataka, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the social science research segment of the research and development sector. It was incorporated on 20 April 2018.
The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U73200KA2018PTC112490.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It was led by directors including Rohan Hemant Kamat and Arun Bellandur Papaiah.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at Hno. 543/6 2nd Floor Devarachikkanah Road Bommanahalli Opp. Jaki Factory, Bangalore, Karnataka, India – 560068.
Company details
Contact details
Straximm Therapeutics Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressHno. 543/6 2nd Floor Devarachikkanah Road Bommanahalli Opp. Jaki Factory, Bangalore, Karnataka, India – 560068
- IndustryResearch & Development, Social Science Research
To see the full contact details of Straximm Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Straximm Therapeutics is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Straximm Therapeutics Private Limited, buy the company report.
Financials of Straximm Therapeutics Private Limited
FY 2021 filings availableFinancial Statement Summary
| Metrics | FY 2018-19 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2018-19 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Straximm Therapeutics Private Limited, buy the company report.
Board of directors of Straximm Therapeutics Private Limited
Straximm Therapeutics has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohan Hemant Kamat Also directs: Straximm LLP, Viravecs Labs LLP | Director | 20 Apr 2018 | 8 Years 6 Months | As last reported |
| Arun Bellandur Papaiah Also directs: Straximm LLP, Aten Biotech Private Limited, Avammune Lifesciences Private Limited and 1 more | Director | 20 Apr 2018 | 8 Years 6 Months | As last reported |
| Aditya Kulkarni Also directs: Straximm LLP, Aten Biotech Private Limited, Avammune Lifesciences Private Limited and 1 more | Director | 20 Apr 2018 | 8 Years 6 Months | As last reported |
Legal cases
No court or tribunal cases involving Straximm Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Straximm Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Straximm Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Straximm Therapeutics Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Aditya Kulkarni was appointed as Director on 20 Apr 2018.
Frequently asked questions
Straximm Therapeutics has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Straximm Therapeutics was a private limited company based in Bangalore, Karnataka, India. The company worked in social science research, within the research and development industry. It was incorporated on 20 April 2018 and is registered under CIN U73200KA2018PTC112490. The company has been struck off by the Registrar of Companies and is no longer operational.
Straximm Therapeutics had 3 directors:
- Rohan Hemant Kamat - Director
- Arun Bellandur Papaiah - Director
- Aditya Kulkarni - Director
The CIN (Corporate Identification Number) of Straximm Therapeutics is U73200KA2018PTC112490. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Straximm Therapeutics is at Hno. 5436 2nd Floor Devarachikkanah Road Bommanahalli Opp. Jaki Factory, Bangalore, Karnataka, India – 560068.
Straximm Therapeutics was incorporated on 20 April 2018. It is registered with the Registrar of Companies, Bangalore.
The latest financial statements of Straximm Therapeutics on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2019 are in the company report.
Straximm Therapeutics operated in the research and development industry, in the social science research segment. It worked in this industry before it was struck off.
Aditya Kulkarni was appointed as Director on 20 Apr 2018. Arun Bellandur Papaiah was appointed as Director on 20 Apr 2018. Rohan Hemant Kamat was appointed as Director on 20 Apr 2018.
Straximm Therapeutics can be reached at its registered office: Hno. 5436 2nd Floor Devarachikkanah Road Bommanahalli Opp. Jaki Factory, Bangalore, Karnataka, India – 560068.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
